References
- JohnsonFRBeusterienKÖzdemirSGiving patients a meaningful voice in United States regulatory decision making: the role for health preference researchPatient20171052352628597374
- HoMPGonzalezJMLernerHPIncorporating patient-preference evidence into regulatory decision makingSurg Endosc201529102984299325552232
- HoMSahaAMcClearyKKA framework for incorporating patient preferences regarding benefits and risks into regulatory assessment of medical technologiesValue Health201619674675027712701
- The 21st Century Cures Act (H.R. 34.). Natl. Institutes Heal. Reauthorization. Sec 2001 Available from: https://www.congress.gov/114/bills/hr34/BILLS-114hr34enr.pdfAccessed March 13, 2018
- PerfettoEMBurkeLOehrleinEMEpsteinRSPatient-focused drug development: a new direction for collaborationMed Care201553191725494232
- The Food and Drug AdministrationPDUFA Reauthorization Performance Goals and Procedures Fiscal Years 2018 through 2022 Available from: https://www.fda.gov/downloads/forindustry/userfees/prescription-druguserfee/ucm511438.pdfAccessed March 13, 2018
- MühlbacherACJuhnkeCBeyerARGarnerSPatient-focused benefit-risk analysis to inform regulatory decisions: the European Union perspectiveValue Health201619673474027712699
- MühlbacherACJohnsonFRGiving patients a meaningful voice in European health technology assessments: the role of health preference researchPatient20171052753028597373
- FrankLForsytheLEllisLConceptual and practical foundations of patient engagement in research at the patient-centered outcomes research instituteQual Life Res20152451033104125560774
- HackerKCommunity-Based Participatory ResearchThousand Oaks, CASAGE Publications2013
- HolkupPATripp-ReimerTSaloisEMCommunity-based participatory research: an approach to intervention research with a Native American communityAdv Nurs Sci200427162175
- HyltonCPatient engagement – the PaCER modelTrials201516O2
- MullardAPatient-focused drug development programme takes first stepsNat Rev Drug Discov201312965165223989777
- U.S. Food and Drug Administration [webpage on the Internet]Prescription Drug User Fee Act (PDUFA) – Externally-led Patient-Focused Drug Development MeetingsCenter for Drug Evaluation and Research Available from: https://www.fda.gov/forindustry/userfees/prescription-druguserfee/ucm453856.htmAccessed March 13, 2018
- Food and Drug Administration [webpage on the Internet]Patient Engagement Collaborative Available from: https://www.fda.gov/ForPatients/PatientEngagement/ucm506248.htmAccessed March 13, 2018
- TerrySFTerryPFRauenKAUittoJBercovitchLGAdvocacy groups as research organizations: the PXE International exampleNat Rev Genet20078215716417230202
- RabeharisoaVThe struggle against neuromuscular diseases in France and the emergence of the “partnership model” of patient organisationSoc Sci Med2003572127213614512243
- BoonWBroekgaardenRThe role of patient advocacy organisations in neuromuscular disease R&D – the case of the Dutch neuromuscular disease association VSNNeuromuscul Disord20102014815120106662
- FurlongPBridgesJFPCharnasLHow a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug AdministrationOrphanet J Rare Dis2015108226104810
- SmithSKSeligWHarkerMPatient engagement practices in clinical research among patient groups, industry, and academia in the United States: a surveyPLoS One20151010e014023226465328
- LandyDCBrinichMAColtenMEHornEJTerrySFSharpRRHow disease advocacy organizations participate in clinical research: a survey of genetic organizationsGenet Med201214222322822261756
- UittoJPatient advocacy organizations partner genetic research, and forge the agendaTrends Mol Med2001718211286944
- DomecqJPPrutskyGElraiyahTPatient engagement in research: a systematic reviewBMC Health Serv Res2014148924568690
- JanssenEMSegalJBBridgesJFPA framework for instrument development of a choice experiment: an application to type 2 diabetesPatient20169546547927120338
- HollinILYoungCarolineHansonCBridgesJFPPeayHDeveloping a patient-centered benefit-risk survey: a community-engaged processValue Health201619675175727712702
- ConcannonTWFusterMSaundersTA systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes researchJ Gen Intern Med2014291692170124893581
- MullinsCDAbdulhalimAMLavalleeDCContinuous patient engagement in comparative effectiveness researchJAMA2012307158722511684
- YanceyAKOrtegaANKumanyikaSKEffective recruitment and retention of minority research participantsAnnu Rev Public Health20062712816533107
- PeayHLHollinIFischerRBridgesJFA community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophyClin Ther201436562463724852596
- ShahSGSRobinsonIBenefits of and barriers to involving users in medical device technology development and evaluationInt J Technol Assess Health Care200723113113717234027
- BodisonSCSankaréIAnayaHEngaging the community in the dissemination, implementation, and improvement of health-related researchClin Transl Sci20158681481926546337
- GulRBAliPAClinical trials: the challenge of recruitment and retention of participantsJ Clin Nurs2010191–222723320500260
- GrossDFoggLClinical trials in the 21st century: the case for participant-centered researchRes Nurs Health200124653053911746081
- AitkenCPowerRDwyerRA very low response rate in an on-line survey of medical practitionersAust N Z J Public Health200832328828918578832
- RoussosSTFawcettSBA review of collaborative partnerships as a strategy for improving community healthAnnu Rev Public Health20002136940210884958
- PatelMXDokuVTennakoonLChallenges in recruitment of research participantsAdv Psychiatr Treat20039229238
- LindenHMReischLMHartAAttitudes toward participation in breast cancer randomized clinical trials in the African American community: a focus group studyCancer Nurs200730426126917666974
- PrinzRJSmithEPDumasJELaughlinJEWhiteDWBarrónRRecruitment and retention of participants in prevention trials involving family-based interventionsAm J Prev Med2001201 suppl 1313711146258
- Foundation for Prader-Willi Research [homepage on the Internet] Available from: https://www.fpwr.org/Accessed March 13, 2018
- CassidySBDriscollDJPrader-Willi syndromeEur J Hum Genet200917131318781185
- GoldstoneAPPrader-Willi syndrome: advances in genetics, pathophysiology and treatmentTrends Endocrinol Metab20031511220
- SchlernitzauerMBierhalsAJGearyMDRecruitment methods for intervention research in bereavement-related depression. Five years’ experienceAm J Geriatr Psychiatry1998667749469216
- FeldtkellerEBruckelJKhanMAScientific contributions of ankylosing spondylitis patient advocacy groupsCurr Opin Rheumatol200012423924710910174
- AhmedSMPalermoA-GSCommunity engagement in research: frameworks for education and peer reviewAm J Public Health201010081380138720558798